Status:
TERMINATED
Femoral Nerve Block With Bupivacaine and Adjuvant Dexamethasone in Patients With Hip Fracture
Lead Sponsor:
University of Aarhus
Conditions:
Hip Fracture
Eligibility:
All Genders
55+ years
Phase:
PHASE4
Brief Summary
Prolongation of the analgesic effect of a femoral nerve block from the present 15 hours to 24 hours in patients with hip fracture would have a major impact in order to provide better preoperative anal...
Detailed Description
Patients with hip fractures are most often old, have multiple comorbidities and suffer severe pain. Femoral nerve block as a means of preoperative analgesia for these patients has proven effective in...
Eligibility Criteria
Inclusion
- Clinical suspicion of hip fracture
- Age ≥ 55 years
- Mentally capable of comprehending and using verbal pain score
- Mentally capable of differentiating between pain from the fractured hip and pain from other locations
- Mentally capable of understanding the given information
- Arrival in the emergency room at times when one of the doctors who do the nerve blocks for this investigation are on call
- Verbal pain score (0-10) ≥ 7 with passive leg raise of the fractured leg at the time of inclusion
- Patients informed consent
Exclusion
- Hip fracture not confirmed by x-ray
- Weight \< 40 kg
- Verbal pain score \> 3, 30 minutes after the nerve block
- Verbal pain score \> 5 with passive leg raise, 30 minutes after the nerve block
- Patient has previously been included in this trial
- Ongoing pre traumatic treatment with parenteral or intravenous adrenocortical hormone
- Verbal pain score \> 3 from other locations than the fractured hip
- If the patient wishes to be excluded
- Allergy to local anesthetics or adrenocortical hormone
- Visible infection in the area of the point of needle injection
- Acute inability to comprehend and use verbal pain score
Key Trial Info
Start Date :
March 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT02248870
Start Date
March 1 2015
End Date
September 1 2015
Last Update
September 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Aarhus, Denmark, 8000